Related Experiment Video
Updated: Aug 20, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy
D C Paviour1, J M Schott, J M Stevens
1The Sara Koe PSP Research Centre, Institute of Neurology UCL, London, UK. dpaviour@dementia.ion.ucl.ac.uk
Background:
Most magnetic resonance imaging (MRI) studies of progressive supranuclear palsy (PSP) are cross-sectional and lack post mortem confirmation of the diagnosis. MRI features described previously in PSP correspond to regions of pathological involvement demonstrated in separate studies, but serial MRI with pathological follow up has not been undertaken.
Objective:
To investigate whether regions of increased atrophy rates demonstrated in PSP during life using fluid registered serial MRI correspond with pathological findings in confirmed PSP.
Methods:
A 59 year old male presented with a six month history of balance problems and dysarthria. He had a symmetrical, levodopa unresponsive akinetic-rigid syndrome with a vertical supranuclear gaze palsy. A clinical diagnosis of probable PSP was made. His disease progressed relentlessly and he died five years after onset. Two serial MRI scans undertaken during life were reviewed and fluid (non-linear) registration of the images carried out. Post mortem histopathological analysis of the brain was undertaken to definitively confirm the diagnosis and compare regional pathology with the serial imaging.
Results:
Fluid registration demonstrated greatest rates of atrophy in the brainstem and frontal cortex, in keeping with the distribution of pathology seen at autopsy.
Conclusion:
Fluid registration of serial MRI allows the topography and rates of regional atrophy in PSP to be delineated in life. Atrophy patterns correlated well with regional pathological load. These observations suggest that serial MRI with registration may help differentiate PSP from clinically similar conditions and supports its use as a surrogate marker of disease progression.
Insights
Serial MRI with fluid registration accurately maps brain atrophy in progressive supranuclear palsy (PSP). Atrophy patterns in living patients correlated with autopsy findings, supporting MRI as a disease progression marker.
Area of Science:
- Neuroimaging
- Neuropathology
- Medical diagnostics
Background:
- Progressive supranuclear palsy (PSP) diagnosis often lacks post-mortem confirmation in MRI studies.
- Previous MRI findings in PSP correlate with pathology but lack serial imaging and follow-up.
Observation:
- A patient with probable PSP underwent serial MRI scans over five years.
- Fluid-registered MRI revealed significant atrophy rates.
- Post-mortem brain analysis confirmed PSP pathology.
Findings:
- Greatest atrophy rates were observed in the brainstem and frontal cortex.
- Atrophy patterns identified via serial MRI corresponded with autopsy-confirmed neuropathology.
- Fluid registration effectively delineated regional atrophy topography and rates in vivo.
Implications:
- Serial MRI with registration can map regional atrophy in PSP during life.
- This technique shows promise in differentiating PSP from similar neurological conditions.
- Registered serial MRI may serve as a valuable surrogate marker for tracking PSP progression.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Parkinson's Disease: Overview
Neural Regulation
Parkinson Disease l: Introduction
Alterations in Muscle Tone lll
